Literature DB >> 9917684

Proximal femur fractures after free vascularized fibular grafting to the hip.

F V Aluisio1, J R Urbaniak.   

Abstract

The management of symptomatic femoral head osteonecrosis in young, active patients is troublesome and controversial. At the authors' institution, 707 consecutive free vascularized fibular grafts were performed for femoral head osteonecrosis between October 1979 and October 1995. Patients who underwent this procedure were at increased risk for proximal femur fractures because of the 16 to 21 mm core drilled through the lateral femoral cortex for removal of the avascular bone and placement of the fibular graft. An ongoing prospective database of patients who underwent this procedure was accessed to determine the incidence of and factors associated with postoperative subtrochanteric femur fractures. Eighteen subtrochanteric fractures occurred for an overall incidence of 2.5%. All fractures occurred through the core decompression site in the lateral femoral cortex. The treatment was nonoperative in seven patients and operative in 11. Fourteen of 18 fractures (77%) healed with an average of 4.1 months until radiographically documented union. Four fractures had nonunions develop, three of which later healed with bone grafting and internal fixation, whereas the fourth eventually required conversion to total hip arthroplasty. Twelve fractures in 251 patients occurred when the weightbearing regimen was touchdown weightbearing for the first 6 weeks and five fractures in 456 patients occurred when the weightbearing regimen was changed to nonweightbearing. The results indicate that nonweightbearing in the immediate postoperative period is associated with the lowest fracture rate.

Entities:  

Mesh:

Year:  1998        PMID: 9917684     DOI: 10.1097/00003086-199811000-00026

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  10 in total

Review 1.  Skeletal Blood Flow in Bone Repair and Maintenance.

Authors:  Ryan E Tomlinson; Matthew J Silva
Journal:  Bone Res       Date:  2013-12-31       Impact factor: 13.567

2.  Versatile application of short stem during total hip arthroplasty.

Authors:  Kwang-Jun Oh; Jae-Hyuk Yang
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-11-16

Review 3.  Current concepts on osteonecrosis of the femoral head.

Authors:  Joaquin Moya-Angeler; Arianna L Gianakos; Jordan C Villa; Amelia Ni; Joseph M Lane
Journal:  World J Orthop       Date:  2015-09-18

4.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

5.  Trabecular metal screw implanted for avascular necrosis of the femoral head may complicate subsequent arthroplasty surgery.

Authors:  N Papapietro; A Di Martino; G Niccoli; A Palumbo; G Salvatore; F Forriol; V Denaro
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-07-17

6.  Titanium alloy cage implantation for the treatment of ischemic necrosis of femoral head in dogs.

Authors:  Ruiying Wang; Yan Gao; Shuhua Yang; Cao Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15

7.  A new mode of clinical failure of porous tantalum rod.

Authors:  Kwang-Jun Oh; Dilbans Singh Pandher
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

8.  Results of Total Hip Arthroplasty after Core Decompression with Tantalum Rod for Osteonecrosis of the Femoral Head.

Authors:  Gun-Woo Lee; Kyung-Soon Park; Do-Youn Kim; Young-Min Lee; Kamolhuja Eshnazarovich Eshnazarov; Taek-Rim Yoon
Journal:  Clin Orthop Surg       Date:  2016-02-13

9.  Subtrochanteric Fracture following Removal of a Porous Tantalum Implant.

Authors:  Derek F Amanatullah; Randall Farac; Thomas J McDonald; H David Moehring; Paul E Di Cesare
Journal:  Case Rep Orthop       Date:  2013-12-03

Review 10.  Complication of osteo reconstruction by utilizing free vascularized fibular bone graft.

Authors:  Qifeng Ou; Panfeng Wu; Zhengbing Zhou; Ding Pan; Ju-Yu Tang
Journal:  BMC Surg       Date:  2020-10-02       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.